Venmax Drugs Reports Nil Deviation in Preferential Issue Fund Utilization
Venmax Drugs and Pharmaceuticals Ltd 路 Others (Uncategorized) 路 12 Nov 2026, 10:34 pm
Venmax Drugs Reports Nil Deviation in Preferential Issue Fund Utilization Venmax Drugs and Pharmaceuticals confirmed zero deviation in the utilization of proceeds raised via fully convertible equity warrants on a preferential basis for the quarter ended 30th Sep'26. Out of the planned Rs. 20.05 crore fundraise initiated on 20th Mar'25, the company has raised Rs. 18.49 crore through 92,44,999 warrant conversions. As of 30th Sep'26, funds deployed include Rs. 8.44 crore toward working capital (out of Rs. 10.00 crore allocated) and the entire Rs. 10.05 crore toward general corporate purposes and business acquisitions.
Original exchange filing (PDF)
More announcements from Venmax Drugs and Pharmaceuticals Ltd
- Unaudited Financial Results for the Quarter and Half Year ended September 30, 206. 路 12 Nov 2026
- Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026 路 12 Nov 2026
- Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Unaudited .... 路 12 Nov 2026
- Venmax Drugs and Pharmaceuticals Limited has submitted the Exchange a copy if Scrutinizer report along with voting results of court convened General Meeting held on October 24, 2026. 路 27 Oct 2026
- Venmax Drugs and Pharmaceuticals Limited has informed the Bombay Stock Exchange regarding Proceedings of court convened General Meeting held today i.e. October 24, 2026. 路 24 Oct 2026
- Voting Results along with the Scrutinizers Report of the 37th Annual General Meeting of the Company held on 26th September 2026 through VC/OAVM. 路 28 Sept 2026
- Summary of the proceedings of 37th Annual General Meeting of the shareholders held at 12.30 P.M. through video conferencing mode. 路 26 Sept 2026
- Venmax Drugs and Pharmaceuticals Limited has informed exchange about the meeting of equity shareholders of the Company pursuant to the order passed by Hon. NCLT, Hyderabad bench II in respect .... 路 23 Sept 2026
